Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 12, 2011, Pages 4858-4863

  Suspène, Rodolphe ^a   Aynaud, Marie Ming ^a   Guétard, Denise ^a   Henry, Michel ^a   Eckhoff, Grace ^a   Marchio, Agnès ^b   Pineau, Pascal ^b   Dejean, Anne ^b,c   Vartanian, Jean Pierre ^a   Wain Hobson, Simon ^a  

^a CNRS   (France)

^b Nuclear Organization and Oncogenesis Unit   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; CELL NUCLEUS DNA; CYTIDINE DEAMINASE; MITOCHONDRIAL DNA; UNCLASSIFIED DRUG; URACIL DNA GLYCOSIDASE;

ARTICLE; CATABOLISM; DNA EDITING; DNA METABOLISM; DNA SEQUENCE; HUMAN; HUMAN CELL; MITOCHONDRION; NUCLEIC ACID STRUCTURE, METABOLISM AND FUNCTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SOMATIC HYPERMUTATION;

CYTOSINE DEAMINASE; DNA, MITOCHONDRIAL; FEMALE; GENETIC LOCI; GENOME, HUMAN; HELA CELLS; HEPADNAVIRIDAE; HUMANS; MALE; MUTATION; NEOPLASMS; RETROVIRIDAE; URACIL-DNA GLYCOSIDASE;

EID: 79953194132     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1009687108     Document Type: Article

References (38)

1. Jarmuz A, et al. (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79:285-296. (Pubitemid 34211936)
2. Conticello SG, Thomas CJ, Petersen-Mahrt SK, Neuberger MS (2005) Evolution of the AID/ APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol Biol Evol 22:367-377. (Pubitemid 40130201)
3. Di Noia JM, Neuberger MS (2007) Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem 76:1-22.
4. Bonvin M, et al. (2006) Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 43: 1364-1374. (Pubitemid 43980116)
5. Koning FA, et al. (2009) Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 83:9474-9485.
6. Refsland EW, et al. (2010) Quantitative profiling of the full APOBEC3mRNA repertoire in lymphocytes andtissues: Implications for HIV-1 restriction. Nucleic Acids Res 38:4274-4284.
7. Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS (2010) APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol 17:222-229.
8. Wang FX, Huang J, Zhang H, Ma X, Zhang H (2008) APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells. J Gen Virol 89:722-730.
9. Chelico L, Pham P, Calabrese P, Goodman MF (2006) APOBEC3G DNA deaminase acts processively 3′ - > 5′ on single-stranded DNA. Nat Struct Mol Biol 13:392-399. (Pubitemid 43881578)
10. Harris RS, et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809. (Pubitemid 36724943)
11. Henry M, et al. (2009) Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. PLoS ONE 4:e4277.
12. Lecossier D, Bouchonnet F, Clavel F, Hance AJ (2003) Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300:1112. (Pubitemid 36583087)
13. Mangeat B, et al. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103. (Pubitemid 36834849)
14. Mariani R, et al. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114:21-31. (Pubitemid 36859838)
15. Suspène R, et al. (2005) Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci USA 102:8321-8326. (Pubitemid 40800087)
16. Wiegand HL, Doehle BP, Bogerd HP, Cullen BR (2004) A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J 23: 2451-2458. (Pubitemid 38954852)
17. Vartanian JP, et al. (2010) Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog 6:e1000928.
18. Vartanian JP, Guétard D, Henry M, Wain-Hobson S (2008) Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 320:230-233. (Pubitemid 351521418)
19. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458:509-513.
20. Stetson DB, Ko JS, Heidmann T, Medzhitov R (2008) Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134:587-598.
21. Suspène R, Henry M, Guillot S, Wain-Hobson S, Vartanian JP (2005) Recovery of APOBEC3-edited human immunodeficiency virus G->A hypermutants by differential DNA denaturation PCR. J Gen Virol 86:125-129. (Pubitemid 40081158)
22. Beale RC, et al. (2004) Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: Correlation with mutation spectra in vivo. J Mol Biol 337:585-596. (Pubitemid 38326879)
23. Chen K, et al. (2006) Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. J Virol 80:7645-7657. (Pubitemid 44092585)
24. Greagg MA, et al. (1999) A read-ahead function in archaeal DNA polymerases detects promutagenic template-strand uracil. Proc Natl Acad Sci USA 96:9045-9050. (Pubitemid 29374704)
25. Wang Z, Mosbaugh DW (1988) Uracil-DNA glycosylase inhibitor of bacteriophage PBS2: Cloning and effects of expression of the inhibitor gene in Escherichia coli. J Bacteriol 170:1082-1091.
26. Imai K, et al. (2003) Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 4: 1023-1028. (Pubitemid 37265924)
27. LaRue RS, et al. (2008) The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol Biol 9:104.
28. Kavli B, et al. (2005) B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil. J Exp Med 201: 2011-2021. (Pubitemid 41002936)
29. Chen R, Le Rouzic E, Kearney JA, Mansky LM, Benichou S (2004) Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. J Biol Chem 279:28419-28425. (Pubitemid 38900122)
30. Benjamin J, Ganser-Pornillos BK, Tivol WF, Sundquist WI, Jensen GJ (2005) Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography. J Mol Biol 346:577-588.
31. Watts NR, et al. (2002) The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. EMBO J 21:876-884. (Pubitemid 34206161)
32. Suspène R, et al. (2004) APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res 32:2421-2429. (Pubitemid 38854796)
33. Okazaki IM, et al. (2003) Constitutive expression of AID leads to tumorigenesis. J Exp Med 197:1173-1181.
34. Takai A, et al. (2009) A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations. Oncogene 28:469-478.
35. Yamanaka S, et al. (1995) Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci USA 92:8483-8487.
36. Greenman C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446:153-158. (Pubitemid 46398669)
37. Pleasance ED, et al. (2010) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463:184-190.
38. Sjöblom T, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274. (Pubitemid 44571966)